- Home
- EHAB vs ETON Comparison
EHAB vs ETON Comparison
Compare EHAB & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- ETON
- Stock Information
- Founded
- EHAB 2014
- ETON 2017
- Country
- EHAB United States
- ETON United States
- Employees
- EHAB N/A
- ETON N/A
- Industry
- EHAB Hospital/Nursing Management
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- EHAB Health Care
- ETON Health Care
- Exchange
- EHAB Nasdaq
- ETON Nasdaq
- Market Cap
- EHAB 401.6M
- ETON 388.3M
- IPO Year
- EHAB N/A
- ETON 2018
- Fundamental
- Price
- EHAB $7.07
- ETON $14.54
- Analyst Decision
- EHAB Buy
- ETON Strong Buy
- Analyst Count
- EHAB 2
- ETON 3
- Target Price
- EHAB $8.75
- ETON $29.67
- AVG Volume (30 Days)
- EHAB 810.2K
- ETON 636.4K
- Earning Date
- EHAB 08-05-2025
- ETON 08-07-2025
- Dividend Yield
- EHAB N/A
- ETON N/A
- EPS Growth
- EHAB N/A
- ETON N/A
- EPS
- EHAB N/A
- ETON N/A
- Revenue
- EHAB $1,032,300,000.00
- ETON $48,327,000.00
- Revenue This Year
- EHAB $4.66
- ETON $103.21
- Revenue Next Year
- EHAB $4.99
- ETON $51.34
- P/E Ratio
- EHAB N/A
- ETON N/A
- Revenue Growth
- EHAB N/A
- ETON 40.88
- 52 Week Low
- EHAB $6.85
- ETON $3.25
- 52 Week High
- EHAB $10.91
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- EHAB 21.84
- ETON 44.22
- Support Level
- EHAB $7.07
- ETON $13.78
- Resistance Level
- EHAB $7.54
- ETON $16.27
- Average True Range (ATR)
- EHAB 0.36
- ETON 0.83
- MACD
- EHAB -0.18
- ETON 0.20
- Stochastic Oscillator
- EHAB 7.75
- ETON 45.60
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.